Van Andel Institute Board Members Van Andel Institute Trustees David Van Andel Chairman & Chief Executive Officer, Van Andel Institute Joan Budden Former President & Chief Executive Officer, Priority Health John Kennedy President & Chief Executive Officer, Autocam Medical Mark Meijer Founder & President, Life E.M.S. Ambulance Van Andel Research Institute Trustees David Van Andel Chairman & Chief Executive Officer, Van Andel Institute Tom R. DeMeester, M.D. Professor & Chairman Emeritus, Department of Surgery, Keck School of Medicine, University of Southern California James B. Fahner, M.D. Chief of Hematology & Oncology, Helen DeVos Children’s Hospital Michelle Le Beau, Ph.D. Professor of Medicine, Section of Hematology/Oncology; Director, University of Chicago Comprehensive Cancer Center; Director, Cancer Cytogenetics Laboratory, University of Chicago George Vande Woude, Ph.D. Distinguished Scientific Fellow, Emeritus; Founding Research Director, Van Andel Institute Max S. Wicha, M.D. Distinguished Professor of Oncology; Professor, Department of Internal Medicine; Founding Director, University of Michigan Comprehensive Cancer Center Van Andel Education Institute Trustees David Van Andel Chairman & Chief Executive Officer, Van Andel Institute James E. Bultman, Ed.D. President Emeritus, Hope College Susan Keipper Meell Chief Executive Officer, MMS Education Juan R. Olivarez, Ph.D. Distinguished Scholar in Residence for Diversity, Equity & Inclusion, Dorothy A. Johnson Center for Philanthropy, Grand Valley State University; President Emeritus, Aquinas College Teresa Weatherall Neal, Ed.D. (hon) Former Superintendent, Grand Rapids Public Schools (LEFT TO RIGHT) JOHN KENNEDY, DAVID VAN ANDEL, MARK MEIJER & JOAN BUDDEN 48 | VAN ANDEL INSTITUTE ANNUAL REPORT 2020
BOARDS Van Andel Institute Graduate School Board of Directors James B. Fahner, M.D. Division Chief of Pediatric Hematology/Oncology & Senior Administrative Physician for Philanthropy & Community Relations at Helen DeVos Children’s Hospital Peter A. Jones, Ph.D., D.Sc. (hon) Chief Scientific Officer, Van Andel Institute Pamela Kidd, M.D. Medical Medical Director, Hematology & Flow Cytometry Laboratories of Spectrum Health & Helen DeVos Children’s Hospital Karen Klomparens, Ph.D. Vice Chair; Former Dean of the Graduate School & Associate Provost for Graduate Education, Michigan State University Juan R. Olivarez, Ph.D. Chairman of the Board; Distinguished Scholar in Residence for Diversity, Equity & Inclusion, Dorothy A. Johnson Center for Philanthropy, Grand Valley State University; President Emeritus, Aquinas College Mary O’Riordan, Ph.D. Associate Dean of Graduate & Postdoctoral Studies and Frederick C. Neidhardt Collegiate Professor of Microbiology and Immunology, University of Michigan Medical School Danny R. Welch, Ph.D. Founding Chair, Department of Cancer Biology, University of Kansas Cancer Center Van Andel Research Institute External Scientific Advisory Board Sharon Y.R. Dent, Ph.D. (ESAB Chair) Professor & Chair, Department of Epigenetics & Molecular Carcinogenesis; Director, Science Park; Director, Center for Cancer Epigenetics, MD Anderson Cancer Center Xiaodong Cheng, Ph.D. Professor, The University of Texas MD Anderson Cancer Center, Department of Molecular & Cellular Oncology Joseph Ecker, Ph.D. Professor, Plant Molecular & Cellular Biology Laboratory; Director, Genomic Analysis Laboratory, Salk Institute; Howard Hughes Medical Institute Investigator Theresa Guise, M.D. Professor Department of Endocrine Neoplasia & Hormonal Disorders; Chief, Section of Bone & Mineral Disorders at The University of Texas MD Anderson Cancer Center; Cancer Prevention Research Institute of Texas (CPRIT) Scholar; Co-Director, The Rolanette & Berdon Lawrence Bone Disease Program of Texas; Co-Leader, Tumor Microenvironment & Metastasis program of the IU Simon Cancer Center, NCI Comprehensive Cancer Center Tony Hunter, Ph.D. Professor, Molecular & Cell Biology Laboratory; American Cancer Society Professor; Renato Dulbecco Chair; Director, Salk Institute Cancer Center Anthony E. Lang, M.D. Senior Scientist, Krembil Research Institute Mitchell Lazar, M.D., Ph.D. Willard & Rhoda Ware Professor in Diabetes & Metabolic Diseases, Perelman School of Medicine, University of Pennsylvania Thomas J. Montine, M.D., Ph.D. Professor, Pathology, Stanford University Max S. Wicha, M.D. Distinguished Professor of Oncology; Professor, Department of Internal Medicine; Founding Director, University of Michigan Comprehensive Cancer Center VAN ANDEL INSTITUTE ANNUAL REPORT 2020 | 49
Loading...
Loading...
Loading...
Established by Jay and Betty Van Andel in 1996, Van Andel Institute is committed to improving the health and changing the lives of current and future generations, through biomedical research and science education.
Van Andel Institute is a tax-exempt 501(c)(3) charitable organization. EIN 52-2000820
Van Andel Institute is committed to making our website’s content accessible and user friendly to everyone. If you are interested in applying for employment with Van Andel Institute and need special assistance or an accommodation to complete our application process, are having difficulty viewing or navigating the content on this website, or notice any content, feature, or functionality that you believe is not fully accessible to people with disabilities, please call the Human Resources Department at 616-234-5100 or email at vari-employment@vai.org.
Van Andel Institute is an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans.